1. Davis JN. and Day M.L. The Convergence of Hormone Regulation
and Cell Cycle in Prostate Physiology and Prostate Tumorigenesis.
Molecular Biotechnology. 22(2):129-38. 2002.
2. Day, K.C., McCabe, M.T., Zhao, X., Wang, YZ., Davis, J.N.,
Phillips, J., Von Geldern, M., Ried, T., KuKuruga, M.A., Cunha,
G.R., Hayward, S.W., and Day, M.L.: Homozygous Disruption of the
Retinblastoma Gene Alters Cell Cycle and Growth Kinetics but does
not Influence Prostatic Differentiation or Morphogenesis. Journal
of Biological Chemistry. 2002. 277(46): 44475-44484.
3. Rios-Doria, J., Day, K.C., Kuefer, R., Rashid, M.G. and Day,
M.L. Calpain-mediated Inactivation of E-cadherin in Prostate and
Mammary Epithelial Cells. Journal of Biological Chemistry. 278(2):1372-9.
2003.
4. Kuefer R, Hofer MD, Gschwend JE, Pienta KJ, Sanda MG, Chinnaiyan
AM, Rubin MA and Day ML. The role of an 80 kDa fragment of E-cadherin
in the metastatic progression of prostate cancer. Clin. Cancer
Res. 9(17):6447-52. 2003.
5. Rios-Doria J, Kuefer R, Ethier SP, and Day ML. Cleavage and
activation of b-catenin by calpain in prostate
and mammary tumor cells. Cancer Res. 2004 Oct 15;64(20):7237-40.
6. Rios-Doria J and Day ML. Truncated E-cadherin potentiates cell
death in prostate epithelial cells.
The Prostate. 2005 May 15;63(3):259-68.
7. McCabe MT, Azih O. and Day ML. Rb-Independent Growth Arrest
and Transcriptional Regulation of E2F
Target Genes. Neoplasia Feb;7(2):141-51. 2005.
8. Davis JN, McCabe MT Hayward, SW and Day ML. The Regulation
of COX-2 Expression and
Function by E2F1 in Prostate Epithelium. Cancer Research May 1;65(9):3633-42.
2005.
9. McCabe MT, Davis JN, and Day ML. Regulation of the DNA Methylation
and Gene Silencing
Through the pRb/E2F1 Pathway. Cancer Research May 1;65(9):3624-32. 2005.
10. Kuefer R., Zorn C., Hoefer M., Rubin M. and Day ML. Assessment
of a fragment of E- cadherin as a serum biomarker with predictive
value for prostate cancer. Br J Cancer. June 6;92(11):2018-23.
2005.
11. Hayward S, Wang YZ, Day M.L. Rescue and Isolation of Rb-deficient
Prostate Epithelium
by Tissue Recombination. Cancer Cell Signaling, In Eds. David Terrian. Humana
Press. 2002.
12. McCabe MT, J.A. Low, M.J. Imperiale, K.J. Wojno, and Day ML.
Inhibition of DNA methyltransferase activity prevents tumor progression
in a mouse model of prostate cancer. Cancer Research. 1;66(1):385-92.
2006.
13. McCabe MT, J.A. Low, M.J. Imperiale, and Day ML. Human Polyomavirus
BKV Transcriptionally Activates DNA Methyltransferase 1 Through
the pRb/E2F Pathway. In Press Oncogene.
14. 1. R. Kuefer, K. C. Day, C. G. Kleer,
M. S. Sabel, M. D. Hofer, S. Varambally, C. S. Zorn, A. M. Chinnaiyan,
M. A. Rubin and Mark L. Day. The ADAM15 disintegrin is associated
with aggressive prostate and breast cancer disease. Neoplasia.
2006. 8(4): 319-329.
|